Keywords
How to Cite
Abstract
Diagnosis of inherited thrombocytopenias represents a true challenge owing to heterogeneity of these disorders and the absence of distinctive features in a substantial proportion of patients. Classical diagnostic approach is based on phenotypic characterization followed by molecular analysis of candidate genes guided by clinical suspicion. The introduction of next generation sequencing (NGS), that allows multiple genes analysis, is a high-cost alternative with limited access in our country. The aim of this work was to evaluate the utility of the classical approach in a consecutive cohort of 50 families and to describe the application of NGS in a subgroup of patients without an etiological diagnosis after the initial approach.
Through the conventional approach, an etiologic diagnosis was made in 27 (54%) families. NGS was
performed in 8 that remained without diagnosis after initial characterization, attaining a diagnosis in
4. Combining both approaches, the diagnostic yield was 31/50 (62%) families: 38% MYH9-related disorder, 8% Bernard-Soulier syndrome, 4% gray platelet syndrome, 4% familial platelet disorder with predisposition to leukemia, 6% ANKRD26-related thrombocytopenia, 2% Wiskott-Aldrich syndrome. Most patients without diagnosis had isolated macrothrombocytopenia and mild bleeding. NGS increased the diagnostic rate in this cohort, although it would be necessary to expand the population to establish its actual value in our setting. Therefore, the use of the classical approach and subsequent application of NGS in undiagnosed patients would represent a useful alternative in low-income countries, pointing out that a correct etiological diagnosis enables the detection of syndromic complications, appropriate treatment and adequate genetic counseling.
References
2.- Noris P, Pecci A. Hereditary thrombocytopenias: a growing list of disorders. Hematology 2017. Am Soc Hematol Educ Program.
3.- Lentaigne C, Freson K, Laffan MA y col. Inherited platelet disorders: toward DNA-based diagnosis. Blood 2016; 127:2814-23.
4.- Balduini CL, Cattaneo M, Fabris F y col. Inherited thrombocytopenias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine. Haematologica 2003; 88: 582–92.
5.- Mumford AD, Westbury SK. Genetic techniques used in the diagnosis of inherited platelet disorders. Semin Thromb Hemost 2019; 45 (7): 685-694.
6.- Zaninetti C, Gresele P, Bertomoro A y col. Eltrombopag for the treatment of inherited thrombocytopenias: A phase II clinical trial. Haematologica 2020 105: 820-828.
7.- Glembotsky AC, Marta RF, Pecci A y col. International collaboration as a tool for diagnosis of patients with inherited thromboytopenia in the setting of a developing country. J Thromb Haemost 2012; 10(8): 1653-61.
8.- Glembotsky AC, Bluteau D, Espasandin YR y col. Mechanisms underlying platelet function defect in a pedigree with FPD/AML: potential role for candidate RUNX1-targets. Journal of Thrombosis and Haemostasis 2014;12(5):761-72.
9.- Pecci A, Klersy C, Gresele P y col. MYH9-related Disease: A novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations. Hum Mutat 2014, 35 (2), 236-47.
10.- Savoia A, Kunishima S, De Rocco D y col. Spectrum of the mutations in Bernard-Soulier syndrome. Hum Mutat. 2014;35(9):1033-45.
11.- Bottega R, Nicchia E, Alfano C y col. Gray platelet syndrome: Novel mutations of the NBEAL2 gene. Am J Hematol. 2017;92(2):E20-E22.
12.- Heller PG, Glembotsky AC, Gandhi MJ y col. Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation. Blood 2005 15;105(12):4664-70.
13.- Odstrcil-Bobillo MS, Kohan D, Heller PG y col. Ileitis as presentation of lymphoma in Wiskott-Aldrich Syndrome Medicina (B Aires) 2020; 80(1): 81-83.
14.- Noris P, Pecci A, Di Bari F y col. Application of a diagnostic algorithm for inherited thrombocytopenias to 46 consecutive patients. Haematologica. 2004;89(10):1219-25.
15.- Simeoni I, Stephens JC, Hu F y col. A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders. Blood 2016; 127(23): 2791-803.
16.- Bastida JM, Lozano ML, Benito R y col. Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders. Haematologica. 2018;103(1):148-62.
All material published in the journal HEMATOLOGÍA (electronic and print version) is transferred to the Argentinean Society of Hematology. In accordance with the copyright Act (Act 11 723), a copyright transfer form will be sent to the authors of approved works, which has to be signed by all the authors before its publication. Authors should keep a copy of the original since the journal is not responsible for damages or losses of the material that was submitted. Authors should send an electronic version to the email: revista@sah.org.ar